Overview

Effect of Dexlansoprazole on Bone Homeostasis

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of dexlansoprazole modified release (MR), once daily (QD), on bone homeostasis.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Dexlansoprazole
Esomeprazole
Lansoprazole